W3C

Semantic Web Health Care and Life Sciences Charter Questionnaire

This is a public questionnaire to guide development of the upcoming HCLS IG charter and use cases. Please indicate here if you would like to review the use cases when they are developed: .

This questionnaire is open for answers until 23:59, Boston time on 2011-04-30. Answers received after that time may not be counted.

The results of this questionnaire are available only to the W3C Team.

If you cannot use this on-line questionnaire, you may send your answers by email to team-hcls-chairs@w3.org.


The W3C is considering continuing the work of the current Semantic Web Health Care and Life Sciences Interest Group. As the potential work areas for this group are diverse, this form offers potential participants the opportunity to express their interests and priorities. The results will help us assess the areas with the most interest and enthusiasm and draft charters for a Working Group and/or Interest Group. A Working Group charter would include a specific deliverables schedule, informed by the feedback from this questionnaire. An Interest Group charter would be less constrained and be designed to facilitate discussion. This questionnaire is expected to take at around 30 minutes; please contact us for clarifications or suggestions.

Questionnaire

Name

What is your name?

Email (required)

What is your email address?

Organization

What organization do you work for?

Role

What role do you have in this organization?

A variety of work items have been suggested for the successor to HCLSIG. The next section, Common Activities, lists general work items that apply to Biological Sciences, Tailored Therapeutics and Translational Medicine, Drug Safety and Health Care. If there are work items you would like to participate in, or which you feel need W3C attention, please list them in the space provided at the end of the questionnaire.

Next to each potential area of work listed below is a participation column with the following choice menu:

To the right of that is a comments field for comments on this work item. The field has no text limit.

Many of the work items use weak verbs like "help" or "facilitate". This is because we don't want to prescribe a particular deliverable in the wording of the work item. You may indicate your preferred deliverables in the deliverables question or specify it in the comments section next to the work item.

Common Activities
participation comments
Bridge and enhance biomedical vocabularies
Work with data providers to make data available in RDF
Work with OBI and vendors to design standards for communicating product catalog information about, e.g., instrumentation and reagents
Characterize reasoning systems with respect to expressivity and scalability, as applied to data sets of interest to the community
Host seminars to educate HCLS community about the Semantic Web
Explore/develop database federation
Enable distributed annotations (e.g. common terms for identification, annotation ontology, ...)
Work on standard RDF representation of text mining output to facilitate automated annotation
Biological Sciences
participation comments
Bridge biological vocabularies (e.g, OBO, BioPAX, MESH)
Help make biological data (e.g. EBI, NCBI and vendor data) available in RDF
Help a research group make its experimental data available in RDF
Integrate omics data (e.g. genomics, proteomics, metabolomics)
Determine scalability of reasoning over biological data
Solicit participation from organism biologists (e.g. taxonomy, ecology, biogeography)
Tailored Therapeutics and Translational Medicine
participation comments
Bridge clinical vocabularies (e.g. SNOMED, ICD9, CDISC)
Help make clinical trial data (e.g. http://lillytrials.com/) available in RDF
Integrate publication, image, pathway and phenotypic data over chemical/target data sets
Connect pre-clinical and clinical trial data with clinical decision support knowledge
Educational outreach to clinical standards organizations
Drug Safety
participation comments
Drug safety data exchange and submission
Integrate toxicology, clinical trials safety and post-market surveillance data
Facilitate adverse events detection and safety signal identification/surveillance by making clinical trials data, electronic health records and voluntary reporting data available in RDF
Solicit participation from pharma companies, FDA, and CDISC
Health Care
participation comments
Bridge health care term sets (e.g. HL7, LOINC)
Bridge health care ontologies (e.g. SNOMED CT, openEHR, GALEN)
Coordinate healthcare rulesets with ongoing effort towards rule standards(e.g. LOA Medical Theories)
Development and maintenance of knowledge-bases for clinical decision support systems containing the latest wisdom from research, content suppliers and medical societies
Help make patient records available in RDF, addressing privacy issues
Help make clinical data (e.g. electronic health records) interoperable using RDF
RDF-ize demographic and scientific data sources used by public health organizations to anticipate and respond to situations that require their attention
Standardize semantic web practices for medical image annotation and markup
Support epidemiological research by developing RDF exchange formats to share treatment outcomes, drug responses, or data relevant to emerging health threats
Other work items

Please list subject areas or work items that you would like covered by these groups, and that have not been mentioned in the questions above:

Deliverables

What kinds of deliverables would you find useful: Please rank the following from 7, most to 1, least useful:

7 . . 4 . . 1
:
Evaluation of HCLS

In order to improve the work of the HCLS IG, we need to know how we've been doing. Following is an evaluation of the HCLS IG task forces and questions about how we've been doing at:

  • requirements — gathering use cases and requirements to guide technical contributions.
  • technical — descriptive or programatic contributions.
  • outreach — sharing the contributions with the rest of the world.
requirements technical outreach comments/suggestions
goodpoor goodpoor goodpoor
goodpoor goodpoor goodpoor
goodpoor goodpoor goodpoor
goodpoor goodpoor goodpoor
goodpoor goodpoor goodpoor
goodpoor goodpoor goodpoor
goodpoor goodpoor goodpoor
Comments

Please list any additional comments:


Eric Prud'hommeaux
$Id: HCLSForm.html,v 1.16 2011/05/26 22:29:08 eric Exp $